Carla Valsecchi

6PUBLICATIONS
18CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyMedical infection agents (incl. prions)Immunogenetics (incl. genetic immunology)Medical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 11, 2025
Implementing an Assay Detecting Anti-Drug Antibody against Emicizumab: Experience from One Center in France.

Claire Auditeau, Carla Valsecchi, Nûn Kalim Bentounes

|Mar 26, 2024
Predictive parameters for spontaneous joint bleeding during emicizumab prophylaxis.

Sara Arcudi, Roberta Gualtierotti, Erica Scalambrino

|Oct 28, 2022
Reduced FVIII recovery associated with anti-FVIII PEG antibodies after BNT162b2 SARS-CoV-2 vaccination.

Carla Valsecchi, Roberta Gualtierotti, Sara Arcudi

|Dec 28, 2020
Characterization of the neutralizing anti-emicizumab antibody in a patient with hemophilia A and inhibitor.

Carla Valsecchi, Marco Gobbi, Marten Beeg

|Dec 14, 2020
IgG subclasses as biomarkers for persistence of factor VIII inhibitors in previously untreated patients with severe haemophilia A.

Flora Peyvandi, Syna Miri, Paolo Bucciarelli

|Oct 07, 2019
Evaluation of a New, Rapid, Fully Automated Assay for the Measurement of ADAMTS13 Activity.

Carla Valsecchi, Maribel Mirabet, Ilaria Mancini

Pageof 1